GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Seoul Pharma Co Ltd (XKRX:018680) » Definitions » Deferred Tax

Seoul Pharma Co (XKRX:018680) Deferred Tax : ₩-12 Mil (TTM As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Seoul Pharma Co Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Seoul Pharma Co's change in deferred tax for the three months ended in Mar. 2025 was ₩16 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-12 Mil.

Seoul Pharma Co Deferred Tax Historical Data

The historical data trend for Seoul Pharma Co's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seoul Pharma Co Deferred Tax Chart

Seoul Pharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only 167.53 96.14 -1,974.61 526.39 61.86

Seoul Pharma Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.25 42.86 -175.44 105.18 15.52

Seoul Pharma Co Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-12 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Seoul Pharma Co Deferred Tax Related Terms

Thank you for viewing the detailed overview of Seoul Pharma Co's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Seoul Pharma Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Seoul Pharma Co Ltd (XKRX:018680) » Definitions » Deferred Tax
Comparable Companies
XKRX:053950 XKRX:200230 XKRX:314140 XKRX:034940 XKRX:354390 XKRX:018620 XKRX:318010 XKRX:114450 XKRX:044960 XKRX:017180 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
21, Banpo-daero, Seocho-gu, Seoul, KOR, 06710
Website
http://www.seoulpharma.com
Seoul Pharma Co Ltd is engaged in manufacturing and distribution of pharmaceuticals products in South Korea. Its products portfolio consists of drugs for the cardiovascular system, respiratory system, and digestive system, drugs for hypertension, antipyretics, drugs for skin disease, drugs for a cough as well as ointments, among others.

Seoul Pharma Co Headlines

No Headlines